Compare Novo Nordisk A/S (NVO) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs United Parcel Service Inc — how do they compare? Novo Nordisk A/S trades at $37.99 (market cap $168.73B), while United Parcel Service Inc trades at $94.21 (market cap $78.52B). The key difference: Novo Nordisk A/S is far larger — about 2.1× United Parcel Service Inc's market cap, and United Parcel Service Inc pays the higher dividend (7.11%). Which is the better fit depends on your goals — on Pluang, investors hold Novo Nordisk A/S for 116 Days and United Parcel Service Inc for 141 Days on average.
| NVO | UPS | |
|---|---|---|
Market Cap | $168.73B | $78.52B |
Volume | 13,531,267 | 5,159,366 |
Sector | Health | Industrials |
52-Week High | $63.98 | $120.00 |
52-Week Low | $35.29 | $82.87 |
Typical Hold Time | 116 Days | 141 Days |
Enterprise Value | $183.05B | $102.54B |
Dividend Yield | 4.7% | 7.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novo Nordisk (NVO) trades at $38.18, up 1.73% with strong fundamentals including 35.35% net margin and 59.82% ROE. The stock shows mixed technical signals with bullish oscillators but bearish moving averages. Recent earnings consistently beat estimates, with Q2 2026 EPS of $0.96 surpassing the $0.82 expectation. The company maintains robust cash flow generation of $119.1B from operations in 2025.
NVO presents compelling value with a 9.71 P/E ratio and 16.8% upside to the $44.67 consensus target. Key risks include FDA regulatory delays for hemophilia drug denecimig and intensifying competition from Eli Lilly in obesity treatments. The bullish analyst consensus (59% buy ratings) supports the growth outlook despite near-term headwinds.
UPS trades at $94.11, up 1.07% with bearish technical signals but strong fundamentals including a 17.15 P/E ratio and 29.66% ROE. The company has beaten earnings estimates for three consecutive quarters, though revenue has declined from $100.3B in 2022 to $88.7B in 2025. Recent developments include the UPS Secure Commerce platform launch and TikTok Shop partnership, while analysts maintain a $118.67 consensus price target despite near-term margin pressures.
UPS presents a value opportunity with attractive valuation metrics and consistent earnings beats, though declining revenue and competitive pressures from Amazon pose challenges. The 7% dividend yield provides income support, but investors should monitor domestic package volume trends and margin sustainability given recent analyst downgrades and bearish technical indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
